The Wall Street Journal reports –
Doctors and patients alike have noticed that eyelash growth is a side effect of a glaucoma drug called Lumigan, sold by California drug maker Allergan Inc. That phenomenon has set off a race among cosmetics companies to create new eyelash treatments that contain either bimatoprost — the active ingredient in Lumigan — or other so-called prostaglandins found in glaucoma drugs.
Read the full article: Drug That Lengthens Eyelashes Sets Off Flutter
Paid advertisements (not an endorsement):